ijms-logo

Journal Browser

Journal Browser

The Role of Dopamine Neurotransmission in Schizophrenia

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 April 2026 | Viewed by 11

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (UNIFESP), São Paulo CEP 04044-20, Brazil
Interests: drug

Special Issue Information

Dear Colleagues,

Schizophrenia is a complex and heterogeneous psychiatric disorder that affects millions globally, exerting a profound impact on patients, their families, and healthcare systems. Despite decades of research, its underlying molecular and cellular mechanisms remain incompletely understood. Dopaminergic neurotransmission has consistently emerged as a central component in the pathophysiology of schizophrenia, influencing cognition, emotion, and motivation through intricate signaling cascades.

Altered dopaminergic signaling, particularly within the mesolimbic and mesocortical pathways, is strongly associated with the positive and negative symptoms of the disorder. However, recent advances in molecular neuroscience, neuroimaging, and genetics have revealed a complex network of interactions between dopamine and other neurotransmitter systems, including glutamate, GABA, and serotonin. These findings challenge classical models and open new avenues for understanding neural circuit dysfunction and developing innovative therapeutic strategies.

Led by Prof. Dr. Mirian Hayashi and Dr. Giulia Fidelis, this Special Issue on “The Role of Dopamine Neurotransmission in Schizophrenia” welcomes original research and review articles focusing on molecular-level investigations.

We particularly encourage submissions in the following areas (although not limited to these):

  • Dopaminergic receptor signaling and intracellular pathways;
  • Molecular and cellular mechanisms regulating dopamine synthesis, release, and reuptake;
  • Animal models providing novel molecular insights into schizophrenia;
  • Dopamine-targeted pharmacological and genetic interventions;
  • Translational studies bridging molecular neurobiology with clinical outcomes.

We look forward to receiving your valuable contributions to advance the molecular understanding of dopaminergic mechanisms in schizophrenia and their implications for future therapeutic approaches.

Dr. Mirian Akemi Furuie Hayashi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • schizophrenia
  • dopamine
  • dopaminergic system
  • neurotransmission
  • psychosis
  • pathophysiology
  • molecular psychiatry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop